Tuesday, April 23, 2024 7:00:11 PM
More mistruths (or possible deception) from Dalton
On the IR-Med website (under 'Advisory Board') Dalton is declaring professional endorsements he does not possess and has not duly qualified for.
He claims to be FASHP and CPEL accredited - which he is not. He is not an ASHP Fellow, and is not an ASHP Certified Pharmacy Executive Leader - this was duly confirmed by ASHP this morning.
In addition, they actually list ALL recipients on their website:
https://www.ashp.org/about-ashp/awards/board-...recipients
https://www.ashp.org/professional-development...es-rosters
ASHP is now aware that Dalton is claiming accreditations he does not legitimately possess, I have also informed IR-Med and requested they remove the credits from his Advisory Board biography - I'm sure they will say it was a simple mistake or oversight
CHEERS
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM